Role of M -receptor cholinergic signaling in direct pathway striatal projection neurons during dopamine depletion.

V H Avilés‐Rosas, E A Rendón‐Ochoa, T Hernández-Flores, M Flores-León, C Arias, E Galarraga, J Bargas

Journal: Synapse (New York, N.Y.) 2024;78(2):e22287

PMID: 38427384

Abstract

Direct pathway striatal projection neurons (dSPNs) are characterized by the expression of dopamine (DA) class 1 receptors (D R), as well as cholinergic muscarinic M and M receptors (M R, M R). D R enhances neuronal firing through phosphorylation of voltage-gate calcium channels (Ca 1 Ca channels) activating Gs proteins and protein kinase A (PKA). Concurrently, PKA suppresses phosphatase PP-1 through DARPP-32, thus extending this facilitatory modulation. M R also influences Ca channels in SPNs through Gq proteins and protein kinase C. However, the signaling mechanisms of M R in dSPNs are less understood. Two pathways are attributed to M R: an inhibitory one through Gi/o proteins, and a facilitatory one via the cyclin Cdk5. Our study reveals that a previously observed facilitatory modulation via Ca 1 Ca channels is linked to the Cdk5 pathway in dSPNs. This result could be significant in treating parkinsonism. Therefore, we questioned whether this effect persists post DA-depletion in experimental parkinsonism. Our findings indicate that in such conditions, M R activation leads to a decrease in Ca current and an increased M R protein level, contrasting with the control response. Nevertheless, parkinsonian and control actions are inhibited by the Cdk5 inhibitor roscovitine, suggesting Cdk5's role in both conditions. Cdk5 may activate PP-1 via PKA inhibition in DA depletion. Indeed, we found that inhibiting PP-1 restores control M R actions, implying that PP-1 is overly active via M Rs in DA-depleted condition. These insights contribute to understanding how DA-depletion alters modulatory signaling in striatal neurons. Additional working hypotheses are discussed.

© 2024 Wiley Periodicals LLC.

Address: Instituto de Fisiología Celular, División de Neurociencias, Universidad Nacional Autónoma de México, Ciudad de México, México.; Laboratorio de Psicofarmacología, Unidad de Investigación Interdisciplinaria y de Ciencias de la Salud y Educación, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, Estado de México, México.; Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México.; Facultad de Ciencias, Universidad Nacional Autónoma de México, Ciudad de México, México.; Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.